Global genomics market expected to generate around USD 41.2 billion by 2025, at a CAGR of 14.2% between 2019 and 2025. The global genomics market has been split into deliverables, application, and end user. Based on deliverables, the genomics market includes services and products.
The report covers a forecast and an analysis of the genomics market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints of the bioinformatics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the genomics market on a global and regional level.
In order to give the users of this report a comprehensive view of the genomics market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides a company market share analysis to give a broader overview of the key players in the genomics market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the genomics market on a global and regional basis.
The study provides a decisive view of the genomics market based on deliverables, application, end-user, and region. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa which is further divided into major countries including the U.S., Germany, France, UK, China, Japan, India, and Brazil.
Some key players in the global genomics market are Illumina, Inc., Thermo Fisher Scientific, Inc., QIAGEN N.V., Eurofins Scientific, Agilent Technologies, Inc., GE Healthcare, BGI, Bio-Rad Laboratories, Inc., Oxford Nanopore Technologies, and F. Hoffmann-La Roche Ltd.
This report segments the global genomics market as follows: